Immunization, Hib3 in Marshall Islands
Marshall Islands: Immunization, Hib3 was 72.0% in 2024. ▲ Rising
Immunization, Hib3 in Marshall Islands, 2000–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
The most recent figure for immunization, hib3 in Marshall Islands is 72.0%, measured in 2024.
Compared with earlier readings it is up 10.8% over ten years.
Over the whole period, immunization, hib3 in Marshall Islands peaked at 99.0% in 2009 and was at its lowest, 45.0%, in 2000.
Marshall Islands ranks 160th of 191 countries on this measure, in the bottom quarter.
The long-run direction has been consistently rising across the 25 years of available data.
Immunization, Hib3 in Marshall Islands, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 2000 | 45.0% | — |
| 2001 | 45.0% | +0.0% |
| 2002 | 80.0% | +77.8% |
| 2003 | 70.0% | -12.5% |
| 2004 | 46.0% | -34.3% |
| 2005 | 69.0% | +50.0% |
| 2006 | 60.0% | -13.0% |
| 2007 | 83.0% | +38.3% |
| 2008 | 92.0% | +10.8% |
| 2009 | 99.0% | +7.6% |
| 2010 | 92.0% | -7.1% |
| 2011 | 80.0% | -13.0% |
| 2012 | 67.0% | -16.2% |
| 2013 | 66.0% | -1.5% |
| 2014 | 65.0% | -1.5% |
| 2015 | 70.0% | +7.7% |
| 2016 | 58.0% | -17.1% |
| 2017 | 65.0% | +12.1% |
| 2018 | 72.0% | +10.8% |
| 2019 | 72.0% | +0.0% |
| 2020 | 75.0% | +4.2% |
| 2021 | 72.0% | -4.0% |
| 2022 | 68.0% | -5.6% |
| 2023 | 72.0% | +5.9% |
| 2024 | 72.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 68.9% | 45.0% | 99.0% | 10 |
| 2010s | 70.7% | 58.0% | 92.0% | 10 |
| 2020s | 71.8% | 68.0% | 75.0% | 5 |
Countries ranked near Marshall Islands
- 157 Ethiopia 73.0% compare
- 157 South Sudan 73.0% compare
- 157 Syrian Arab Republic 73.0% compare
- 160 Panama 72.0% compare
- 162 Micronesia, Federated States of 71.0% compare
- 162 Myanmar 71.0% compare
- 162 Philippines 71.0% compare
- 162 Vanuatu 71.0% compare
More health data for Marshall Islands
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 3.09 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,179 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2 deaths (2100)
- Population ages 05-09, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, female, per capita 0.0558 units per person (2025)
- Population ages 05-09, male, annual growth rate -2.38 % change on previous year (2025)
- Population ages 05-09, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, male, per capita 0.0587 units per person (2025)
- Population ages 10-14, female, annual growth rate -3.69 % change on previous year (2025)
Frequently asked questions
- What is immunization, hib3 in Marshall Islands?
- Immunization, hib3 in Marshall Islands was 72.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Marshall Islands?
- The highest recorded value was 99.0% in 2009.
- What is the lowest immunization, hib3 recorded in Marshall Islands?
- The lowest recorded value was 45.0% in 2000.
- How does Marshall Islands rank for immunization, hib3?
- Marshall Islands ranks 160th out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Marshall Islands?
- Over the last ten years it is up 10.8%. The long-run trend across the full record is rising.
- Where does this Marshall Islands data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.